These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26766493)

  • 1. Simotinib as a modulator of P-glycoprotein: substrate, inhibitor, or inducer?
    Huang L; Shen C; Chen Y; Yan H; Cheng Z; Zhu Q
    Anticancer Drugs; 2016 Apr; 27(4):300-11. PubMed ID: 26766493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.
    Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC
    Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31.
    Sun W; Wong ILK; Law HK; Su X; Chan TCF; Sun G; Yang X; Wang X; Chan TH; Wan S; Chow LMC
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells.
    Sinha BK; Bortner CD; Mason RP; Cannon RE
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2806-2814. PubMed ID: 30251669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
    Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines.
    Washio I; Nakanishi T; Ishiguro N; Bister B; Tamai I
    Biopharm Drug Dispos; 2019 Jan; 40(1):32-43. PubMed ID: 30556139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells.
    Kitazaki T; Oka M; Nakamura Y; Tsurutani J; Doi S; Yasunaga M; Takemura M; Yabuuchi H; Soda H; Kohno S
    Lung Cancer; 2005 Sep; 49(3):337-43. PubMed ID: 15955594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel non-natural nucleoside that influences P-glycoprotein activity and mediates drug resistance.
    Eng KT; Berdis AJ
    Biochemistry; 2010 Mar; 49(8):1640-8. PubMed ID: 20104904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding dihydro-β-agarofuran sesquiterpenes from Tripterygium hypoglaucum as the modulators of multi-drug resistance in HepG2/Adr cells.
    Yang T; Wang S; Zheng H; Wang L; Liu D; Chen X; Li R
    Biochem Biophys Res Commun; 2019 Jan; 508(3):742-748. PubMed ID: 30528235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interaction studies reveal that simotinib upregulates intestinal absorption by increasing the paracellular permeability of intestinal epithelial cells.
    Zhu Q; Liu Z; Li P; Cheng Z
    Drug Metab Pharmacokinet; 2014; 29(4):317-24. PubMed ID: 24522198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosloflavone from Fissistigma petelotii ameliorates oncogenic multidrug resistance by STAT3 signaling modulation and P-glycoprotein blockade.
    Chien PY; Lan YH; Wu IT; Huang YP; Hung CC
    Phytomedicine; 2024 Jan; 123():155210. PubMed ID: 38006807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein.
    Duran GE; Derdau V; Weitz D; Philippe N; Blankenstein J; Atzrodt J; Sémiond D; Gianolio DA; Macé S; Sikic BI
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1095-1103. PubMed ID: 29675746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism.
    Xu Q; Guo J; Chen W
    Biochem Biophys Res Commun; 2019 Jan; 508(3):882-888. PubMed ID: 30538042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells.
    Tay Z; Koo SH; Nguyen TT; Tan TS; Chen ML; Chin CF; Lim KK; Ang WH; Bay BH; Lee EJ; Chen ES
    Curr Med Chem; 2014; 21(2):251-60. PubMed ID: 24059229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
    Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
    Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Pharmacological Characterization of N-(4-(2 (6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine Derivatives: Novel Inhibitors Reversing P-Glycoprotein-Mediated Multidrug Resistance.
    Qiu Q; Liu B; Cui J; Li Z; Deng X; Qiang H; Li J; Liao C; Zhang B; Shi W; Pan M; Huang W; Qian H
    J Med Chem; 2017 Apr; 60(8):3289-3302. PubMed ID: 28355069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.